Rajiv Dhir

ORCID: 0000-0001-6424-6112
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Molecular Biology Techniques and Applications
  • Medical Imaging and Pathology Studies
  • Cell Adhesion Molecules Research
  • Renal and related cancers
  • Urinary and Genital Oncology Studies
  • Occupational and environmental lung diseases
  • Urologic and reproductive health conditions
  • Urinary Bladder and Prostate Research
  • Epigenetics and DNA Methylation
  • Cancer-related molecular mechanisms research
  • Cancer, Lipids, and Metabolism
  • Estrogen and related hormone effects
  • Ferroptosis and cancer prognosis
  • Peptidase Inhibition and Analysis
  • Advanced Proteomics Techniques and Applications
  • RNA Research and Splicing
  • Genetic factors in colorectal cancer
  • RNA modifications and cancer
  • Hormonal and reproductive studies
  • Lung Cancer Treatments and Mutations

University of Pittsburgh
2015-2024

Shadyside Hospital
2006-2024

University of Pittsburgh Medical Center
2015-2024

UPMC Hillman Cancer Center
2008-2020

UPMC Health System
2015-2020

Frederick National Laboratory for Cancer Research
2019

Emory University
2019

Winship Cancer Institute
2019

Leidos (United States)
2019

National Cancer Institute
2019

10.1038/nature10166 article EN Nature 2011-06-28
Rehan Akbani Kadir C. Akdemir Bülent Arman Aksoy Monique Albert Adrian Ally and 95 more Samirkumar B. Amin Harindra Arachchi Arshi Arora J. Todd Auman Brenda Ayala Julien Baboud Miruna Balasundaram Saianand Balu Nandita Barnabas Thomas John Pam Bartlett Boris C. Bastian Stephen B. Baylin Madhusmita Behera D. K. Belyaev Christopher C. Benz Brady Bernard Rameen Beroukhim Natalie Bir Aaron D. Black Tom Bodenheimer Lori Boice Genevieve M. Boland R. Bono Moiz Bootwalla Marcus Bosenberg Jay Bowen Reanne Bowlby Christopher A. Bristow Laura Brockway-Lunardi Denise Brooks Jakub Brzezinski Wiam Bshara Elizabeth Buda William R. Burns Yaron S.N. Butterfield M. Button Tiffany L. Calderone Giancarlo Antonini Cappellini Candace Carter Scott L. Carter Lynn Cherney Andrew D. Cherniack Aaron Chevalier Lynda Chin Juok Cho Raymond J. Cho Yoon‐La Choi Andy Chu Sudha Chudamani Kristian Cibulskis Giovanni Ciriello Amanda Clarke Stephen W. Coons Leslie Cope Daniel Crain Erin Curley Ludmila Danilova Stefania D’Atri Tanja M. Davidsen Michael A. Davies Keith A. Delman John A. Demchok Qing Deng Yonathan Lissanu Deribe Noreen Dhalla Rajiv Dhir Daniel DiCara М С Диникин Michael Dubina J. Stephen Ebrom Sophie Egea Greg Eley Jay Engel Jennifer Eschbacher Konstantin Fedosenko Ina Felau Timothy R. Fennell Martin L. Ferguson Sheila Fisher Keith T. Flaherty Scott Frazer Jessica Frick Victoria Fulidou Stacey Gabriel Jianjiong Gao Johanna Gardner Levi A. Garraway Julie M. Gastier-Foster Carmelo Gaudioso Nils Gehlenborg Giannicola Genovese Mark Gerken Hui Shen Gad Getz

10.1016/j.cell.2015.05.044 article EN publisher-specific-oa Cell 2015-06-01
Adam Abeshouse Jaeil Ahn Rehan Akbani Adrian Ally Samirkumar B. Amin and 95 more Chris Andry Matti Annala Armen Aprikian Joshua Armenia Arshi Arora J. Todd Auman Miruna Balasundaram Saianand Balu Christopher E. Barbieri Thomas Bauer Christopher C. Benz Alain Bergeron Rameen Beroukhim Mario Berríos Adrian Bivol Tom Bodenheimer Lori Boice Arnoud Boot Rodolfo Borges dos Reis Paul C. Boutros Jay Bowen Reanne Bowlby Jeffrey M. Boyd Robert K. Bradley Anne Breggia Fadi Brimo Christopher A. Bristow Denise Brooks Bradley M. Broom Alan H. Bryce Glenn J. Bubley Eric Burks Yaron S.N. Butterfield M. Button David Canes Carlos Gilberto Carlotti Rebecca Carlsen Michel Carmel Peter R. Carroll Scott L. Carter Richard W. Cartun Brett S. Carver June M. Chan Matthew T. Chang Yu Chen Andrew D. Cherniack Simone Chevalier Lynda Chin Juok Cho Andy Chu Eric Chuah Sudha Chudamani Kristian Cibulskis Giovanni Ciriello Amanda Clarke Matthew R. Cooperberg Niall M. Corcoran Anthony J. Costello Janet E. Cowan Daniel Crain Erin Curley Kerstin A. David John A. Demchok Francesca Demichelis Noreen Dhalla Rajiv Dhir Alexandre A. Doueik Bettina F. Drake Heidi Dvinge Natalya Dyakova Ina Felau Martin L. Ferguson Scott Frazer Stephen J. Freedland Yao Fu Stacey Gabriel Jianjiong Gao Johanna Gardner Julie M. Gastier-Foster Nils Gehlenborg Mark Gerken Mark Gerstein Gad Getz Andrew K. Godwin Anuradha Gopalan Markus Graefen Kiley Graim Thomas Gribbin Ranabir Guin Manaswi Gupta Angela Hadjipanayis Syed Haider Lucie Hamel D. Neil Hayes David I. Heiman

10.1016/j.cell.2015.10.025 article EN publisher-specific-oa Cell 2015-11-01
Nishant Agrawal Rehan Akbani Bülent Arman Aksoy Adrian Ally Harindra Arachchi and 95 more L. Sylvia J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Madhusmita Behera Brady Bernard Rameen Beroukhim Justin A. Bishop Aaron D. Black Tom Bodenheimer Lori Boice Arnoud Boot Jay Bowen Reanne Bowlby Christopher A. Bristow Robin Brookens Denise Brooks Robert Bryant Elizabeth Buda Yaron S.N. Butterfield Tobias Carling Rebecca Carlsen Scott L. Carter Sally E. Carty Timothy A. Chan Amy Y. Chen Andrew D. Cherniack Dorothy Cheung Lynda Chin Juok Cho Andy Chu Eric Chuah Kristian Cibulskis Giovanni Ciriello Amanda Clarke Gary L. Clayman Leslie Cope John A. Copland Kyle Covington Ludmila Danilova Tanja M. Davidsen John A. Demchok Daniel DiCara Noreen Dhalla Rajiv Dhir Sheliann S. Dookran Gideon Dresdner Jonathan Eldridge Greg Eley Adel K. El‐Naggar Stephanie Eng James A. Fagin Timothy R. Fennell Robert L. Ferris Sheila Fisher Scott Frazer Jessica Frick Stacey Gabriel Ian Ganly Jianjiong Gao Levi A. Garraway Julie M. Gastier-Foster Gad Getz Nils Gehlenborg Ronald Ghossein Richard A. Gibbs Thomas J. Giordano Karen Gomez-Hernandez Jonna Grimsby Benjamin Groß Ranabir Guin Angela Hadjipanayis Hollie A. Harper D. Neil Hayes David I. Heiman James G. Herman Katherine A. Hoadley Matan Hofree Robert A. Holt Alan P. Hoyle Franklin W. Huang Mei Huang Carolyn M. Hutter Trey Ideker Lisa Iype Anders J. Skanderup Joshua M. Stuart Corbin D. Jones Steven J.M. Jones L. Sylvia Electron Kebebew Fadlo R. Khuri Jaegil Kim Roger Kramer

<h2>Summary</h2> Papillary thyroid carcinoma (PTC) is the most common type of cancer. Here, we describe genomic landscape 496 PTCs. We observed a low frequency somatic alterations (relative to other carcinomas) and extended set known PTC driver include <i>EIF1AX</i>, <i>PPM1D</i>, <i>CHEK2</i> diverse gene fusions. These discoveries reduced fraction cases with unknown oncogenic from 25% 3.5%. Combined analyses variants, expression, methylation demonstrated that different groups lead...

10.1016/j.cell.2014.09.050 article EN cc-by-nc-nd Cell 2014-10-01
Benjamin J. Raphael Ralph H. Hruban Andrew J. Aguirre Richard A. Moffitt Jen Jen Yeh and 95 more Chip Stewart A. Gordon Robertson Andrew D. Cherniack Manaswi Gupta Gad Getz Stacey Gabriel Matthew Meyerson Carrie Cibulskis Suzanne S. Fei Toshinori Hinoue Hui Shen Peter W. Laird Shiyun Ling Yiling Lu Gordon B. Mills Rehan Akbani Phillipe Loher Eric Londin Isidore Rigoutsos Aristeidis G. Telonis Ewan A. Gibb Anna Goldenberg Aziz M. Mezlini Katherine A. Hoadley Eric A. Collisson Eric S. Lander Bradley A. Murray Julian M. Hess Mara Rosenberg Louis Bergelson Hailei Zhang Juok Cho Grace Tiao Jaegil Kim Dimitri Livitz Ignaty Leshchiner Brendan Reardon Eliezer M. Van Allen Atanas Kamburov Rameen Beroukhim Gordon Saksena Steven E. Schumacher Michael S. Noble David I. Heiman Nils Gehlenborg Jaegil Kim Michael S. Lawrence Volkan Adsay Gloria M. Petersen David S. Klimstra Nabeel Bardeesy Mark D.M. Leiserson Reanne Bowlby L. Sylvia İnanç Birol Karen Mungall Sara Sadeghi John N. Weinstein Paul T. Spellman Yuexin Liu Laufey T. Ámundadóttir Joel E. Tepper Aatur D. Singhi Rajiv Dhir Paul Drwiega Thomas C. Smyrk Lizhi Zhang Paula Kim Jay Bowen Jessica Frick Julie M. Gastier‐Foster Mark Gerken Kevin Lau Kristen Leraas Tara M. Lichtenberg Nilsa C. Ramirez Jeremy Renkel Mark E. Sherman Lisa Wise Peggy Yena Erik Zmuda Juliann Shih Adrian Ally Miruna Balasundaram Rebecca Carlsen Andy Chu Eric Chuah Amanda Clarke Noreen Dhalla Robert A. Holt Steven J.M. Jones Darlene Lee Yussanne Ma Marco A. Marra Michael Mayo

10.1016/j.ccell.2017.07.007 article EN cc-by-nc-nd Cancer Cell 2017-08-01

Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of that most commonly evolves from preexisting adenocarcinoma (PCA). Using Next Generation RNA-sequencing and oligonucleotide arrays, we profiled 7 NEPC, 30 PCA, 5 benign tissue (BEN), validated findings on tumors a large cohort patients (37 169 22 BEN) using IHC FISH. We discovered significant overexpression gene amplification AURKA MYCN in 40% NEPC 5% respectively, evidence they cooperate to induce neuroendocrine phenotype...

10.1158/2159-8290.cd-11-0130 article EN Cancer Discovery 2011-11-01

The incidence of prostate cancer is frequent, occurring in almost one-third men older than 45 years. Only a fraction the cases reach stages displaying clinical significance. Despite advances our understanding carcinogenesis and disease progression, knowledge this still fragmented. Identification genes patterns gene expression will provide more cohesive picture biology.In study, we performed comprehensive analysis on 152 human samples including tissues, tissues adjacent to tumor, organ donor...

10.1200/jco.2004.05.158 article EN Journal of Clinical Oncology 2004-07-14

Prostate cancer is characterized by heterogeneity in the clinical course that often does not correlate with morphologic features of tumor. Metastasis reflects most adverse outcome prostate cancer, and to date there are no reliable or serum biomarkers can reliably predict which patients at higher risk developing metastatic disease. Understanding differences biology organ confined primary tumors essential for new prognostic markers therapeutic targets.Using Affymetrix oligonucleotide arrays,...

10.1186/1471-2407-7-64 article EN cc-by BMC Cancer 2007-04-12

Background Chronic obstructive pulmonary disease (COPD) is a progressive lung characterized by abnormal cellular responses to cigarette smoke, resulting in tissue destruction and airflow limitation. Autophagy degradative process involving lysosomal turnover of components, though its role human diseases remains unclear. Methodology Principal Findings Increased autophagy was observed from COPD patients, as indicated electron microscopic analysis, well increased activation autophagic proteins...

10.1371/journal.pone.0003316 article EN cc-by PLoS ONE 2008-10-01

Rationale: The molecular mechanisms underlying acute exacerbations of idiopathic pulmonary fibrosis (IPF) are poorly understood. We studied the global gene expression signature IPF.Objectives: To understand patterns IPF.Methods: RNA was extracted from 23 stable IPF lungs, 8 lungs with exacerbation (IPF-AEx), and 15 control used for hybridization on Agilent microarrays. Functional analysis genes performed Spotfire Genomica. Gene validations MMP1, MMP7, AGER, DEFA1–3, COL1A2, CCNA2 were by...

10.1164/rccm.200810-1596oc article EN American Journal of Respiratory and Critical Care Medicine 2009-04-11

BackgroundThere is high demand to develop computer-assisted diagnostic tools evaluate prostate core needle biopsies (CNBs), but little clinical validation and a lack of deployment such tools. We report here on blinded study an artificial intelligence (AI)-based algorithm in pathology laboratory for routine use aid diagnosis.MethodsAn AI-based was developed using haematoxylin eosin (H&E)-stained slides CNBs digitised with Philips scanner, which were divided into training (1 357 480 image...

10.1016/s2589-7500(20)30159-x article EN cc-by-nc-nd The Lancet Digital Health 2020-07-27

Neuroendocrine prostate cancer (NEPC), also referred to as anaplastic cancer, is a lethal tumor that most commonly arises in late stages of adenocarcinoma (PCA) with predilection metastasize visceral organs. In the current study, we explore for evidence Aurora kinase A (AURKA) and N-myc (MYCN) gene abnormalities are harbingers treatment-related NEPC (t-NEPC). We studied primary tissue from 15 hormone naïve PCAs, 51 castration-resistant cancers, metastatic tumors 72 patients at different...

10.1593/neo.121550 article EN cc-by-nc-nd Neoplasia 2013-01-01

Abstract Prostate cancer is a biologically heterogeneous disease with considerable variation in clinical aggressiveness. The behavior of prostate can be considered direct or indirect result aberrant alterations gene expression epithelial cells. Identification the patterns gene‐expression that are related to aggressiveness cancers will greatly assist development tools for early detection poor outcome and identification targets future therapeutic intervention. To detect cancers, we performed...

10.1002/mc.10018 article EN Molecular Carcinogenesis 2002-01-01

Talin1 is a focal adhesion complex protein that regulates integrin interactions with ECM. This study investigated the significance of talin1 in prostate cancer progression to metastasis vitro and vivo. overexpression enhanced cell adhesion, migration, invasion by activating survival signals conferring resistance anoikis. ShRNA-mediated loss led significant suppression migration transendothelial inhibition Talin1-regulated via phosphorylation proteins, such as kinase Src, downstream...

10.1158/0008-5472.can-09-2833 article EN Cancer Research 2010-02-17

Current prognostic factors are poor at identifying patients risk of disease recurrence after surgery for stage II colon cancer. Here we describe a DNA microarray-based assay using clinically relevant formalin-fixed paraffin-embedded (FFPE) samples.A gene signature was developed from balanced set 73 with recurrent (high risk) and 142 no (low within 5 years surgery.The 634-probe identified high-risk hazard ratio (HR) 2.62 (P < .001) during cross validation the training set. In an independent...

10.1200/jco.2011.35.4498 article EN Journal of Clinical Oncology 2011-11-08

Abstract Purpose: Steroid hormones and growth factors affect lung cancer, it is possible they act in concert to influence patient outcome. Experimental Design: Primary tumors normal tissue were analyzed for expression localization of estrogen receptor α β-1 (ERα ERβ), aromatase, progesterone (PR), epidermal factor (EGFR). Results: Tumors expressed higher levels ERβ compared matched lung, whereas the reverse was true PR. High cytoplasmic identified as an independent negative prognostic...

10.1158/1078-0432.ccr-10-0992 article EN Clinical Cancer Research 2010-11-10

Abstract The attachment of circulating tumor cells to the blood vessels distant organs is an important step in metastasis. We show here that experimental lung metastasis by two cell lines, B16F1 melanoma and 3LL carcinoma, greatly reduced transgenic mice lack plasma fibronectin. This multifunctional adhesive glycoprotein becomes cross-linked fibrin during clotting. Here, we report eliminating fibronectin from circulation reverses prometastatic effects clotting integrin αvβ3. In vitro studies...

10.1158/0008-5472.can-09-3312 article EN Cancer Research 2010-05-26

Abstract Background Carcinoma cells must circumvent the normally suppressive signals to disseminate. While often considered 'stop' for adherent cells, CXCR3-binding chemokines have recently been correlated positively with cancer progression though molecular basis remains unclear. Results Here, we examined expression and function of two CXCR3 variants in human prostate biopsies cell lines. Globally, both mRNA protein were elevated localized metastatic compared normal. Additionally, CXCR3A...

10.1186/1476-4598-11-3 article EN cc-by Molecular Cancer 2012-01-11

Non-clear cell renal carcinomas (non-ccRCCs) encompass diverse malignant and benign tumors. Refinement of differential diagnosis biomarkers, markers for early prognosis aggressive disease, therapeutic targets to complement immunotherapy are current clinical needs. Multi-omics analyses 48 non-ccRCCs compared with 103 ccRCCs reveal proteogenomic, phosphorylation, glycosylation, metabolic aberrations in RCC subtypes. RCCs high genome instability display overexpression IGF2BP3 PYCR1. Integration...

10.1016/j.xcrm.2024.101547 article EN cc-by Cell Reports Medicine 2024-05-01

Typical high throughput microarrays experiments compare gene expression across two specimen classes - an experimental class and baseline (or comparison) class. The choice of is a major factor in the differential patterns revealed by these experiments. In most studies prostate cancer, histologically malignant tissue chosen as while normal appearing adjacent to tumor (adjacent normal) against which comparison made. However, from free organ donors represents alterative source for studies.

10.1186/1471-2407-5-45 article EN cc-by BMC Cancer 2005-05-13
Coming Soon ...